Cholesterol metabolism and cancer: Molecular mechanisms, immune regulation and an epidemiological perspective (Review)
Open Access
- 17 October 2025
- journal article
- review article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 56 (6) , 1-22
Abstract
Cholesterol and its metabolites exert multifaceted and profound effects on cancer initiation, progression and therapeutic response as well as patient prognosis. The present review systematically summarizes the oncogenic role of cholesterol metabolism in malignancies. Cancer cells extensively remodel cholesterol homeostasis through enhanced synthesis, increased uptake and impaired efflux, thereby sustaining proliferative signaling, suppressing ferroptotic cell death, promoting autophagic survival and facilitating epithelial‑mesenchymal transition, collectively fueling tumor invasion and metastasis. Within the tumor immune microenvironment, cholesterol exhibits dual immunoregulatory roles; it potentiates T‑cell antitumor function while its oxidized derivatives contribute to T‑cell exhaustion. Therapeutic targeting of cholesterol metabolism represents a promising strategy to trigger ferroptosis, reverse chemoresistance and reinvigorate antitumor immunity. Nevertheless, epidemiological evidence regarding the correlation between cholesterol levels and cancer risk remains contentious, underscoring the context‑dependent and complex nature of cholesterol in oncology. Targeting cholesterol metabolism may thus offer a novel integrative approach for cancer therapy, meriting further mechanistic and clinical investigation.Keywords
This publication has 317 references indexed in Scilit:
- Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver DiseaseJAMA Internal Medicine, 2025
- Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 AxisAdvanced Science, 2025
- Cholesterol Depletion‐Enhanced Ferroptosis and Immunotherapy via Engineered NanozymeAdvanced Science, 2024
- Nanoparticle Targeting in Chemo‐Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox BalanceAdvanced Science, 2024
- Statin Use, Cholesterol Level, and Mortality Among Females With Breast CancerJAMA Network Open, 2023
- Immunomodulatory‐Photodynamic Nanostimulators for Invoking Pyroptosis to Augment Tumor ImmunotherapyAdvanced Healthcare Materials, 2022
- Aberrant Cholesterol Metabolism and Wnt/β‐Catenin Signaling Coalesce via Frizzled5 in Supporting Cancer GrowthAdvanced Science, 2022
- Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian CancerJAMA, 2020
- ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetaloneMolecular Oncology, 2018
- Actions of bisphosphonate on bone metastasis in animal models of breast carcinomaCancer, 2000